(Telestock) – Casta Diva Groupa company listed on Euronext Growth Milan and active internationally in the communications sector, has appointed
Alessandro Scattolin49 years old, director of the new Pharma division of Casta Diva Group which is part of the G2 Eventi group company. Scattolin will be supported by Alessandro Capasso and from Silvia Pellò.Casta Diva also announced that a letter of intent for the acquisition of 100% of the shares of a company that has been operating for over 20 years in the event organization sector, mainly in the medical/scientific field, both nationally and internationally, and which boasts among its clients the main multinational Pharma companies and University Institutes of excellence in the European field. society target has a turnover of 7.4 million euros in 2023, with an adjusted ebitda margin of 11.6% and the closing of the acquisition, subject to the outcome of the ongoing due diligence, is expected by the end of the year.
“We realized that in some very specific areas of Live Communication, it is necessary to have particular expertise, which we found to the highest degree in Alessandro Scattolin and his collaborators. These characteristics, combined with the feeling that was immediately created between these new managers and our team, make us think that things will develop quickly as expected – commented the president and CEO of the group, Andrea DeMicheli -. The very important addition of the acquisition of a well-known brand in the sector will act as a further driving force for the growth of the new pharma division of CDG, which will have all our moral and concrete support both in its development phase and in the years to come”.